FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1847568571> ?p ?o ?g. }

• W1847568571 endingPage "33" @default.
• W1847568571 startingPage "23" @default.
• W1847568571 abstract "γδ T cells are attractive effector cells for cancer immunotherapy as they can secrete cytokines abundantly and exert potent cytotoxicity against a wide range of cancer cells. They comprise 1-5% of peripheral blood T cells, the majority expressing the Vγ9Vδ2 T cell receptor that recognizes phosphoantigens. Direct in vivo activation of Vγ9Vδ2 T cells in cancer patients as well as adoptive transfer of ex vivo expanded Vγ9Vδ2 T cells has been investigated in several clinical trials. We previously established a large-scale in vitro expansion method for Vγ9Vδ2 T cells using zoledronate and interleukin-2 (IL-2). We found that Vγ9Vδ2 T cells from patients with advanced cancer as well as from healthy donors underwent extensive proliferation under these conditions. Such cultured Vγ9Vδ2 T cells retained cytokine secretion capacity and mediated cytotoxicity against a variety of cancer cell lines. Recently, we conducted a phase I clinical study to evaluate safety and potential anti-tumor effects of re-infusing ex vivo expanded γδ T cells in patients with advanced or recurrent non-small-cell lung cancer (NSCLC) refractory to or intolerant of current conventional treatments. There were no severe adverse events related to the therapy. All patients remained alive during the study period with a median survival of 589 days and median progression-free survival of 126 days. Six patients had stable disease (SD), whereas the remaining six evaluable patients experienced progressive disease (PD) four weeks after the sixth transfer. We conclude that adoptive transfer of zoledronate-expanded γδ T cells is safe and feasible in patients with NSCLC, refractory to other treatments." @default.
• W1847568571 created "2016-06-24" @default.
• W1847568571 creator A5003582794 @default.
• W1847568571 creator A5013524621 @default.
• W1847568571 creator A5030744700 @default.
• W1847568571 creator A5089569598 @default.
• W1847568571 date "2014-02-01" @default.
• W1847568571 modified "2023-10-12" @default.
• W1847568571 title "γδ T cell therapy for the treatment of non-small cell lung cancer." @default.
• W1847568571 cites W1535243328 @default.
• W1847568571 cites W1904545123 @default.
• W1847568571 cites W1972245883 @default.
• W1847568571 cites W1972525178 @default.
• W1847568571 cites W1978029914 @default.
• W1847568571 cites W1979819707 @default.
• W1847568571 cites W1981756981 @default.
• W1847568571 cites W1987608235 @default.
• W1847568571 cites W1988862024 @default.
• W1847568571 cites W1998143989 @default.
• W1847568571 cites W2001498331 @default.
• W1847568571 cites W2007281165 @default.
• W1847568571 cites W2026391181 @default.
• W1847568571 cites W2036501031 @default.
• W1847568571 cites W2043545955 @default.
• W1847568571 cites W2043756084 @default.
• W1847568571 cites W2056204715 @default.
• W1847568571 cites W2060716894 @default.
• W1847568571 cites W2064920472 @default.
• W1847568571 cites W2069947334 @default.
• W1847568571 cites W2089494568 @default.
• W1847568571 cites W2091954193 @default.
• W1847568571 cites W2104616589 @default.
• W1847568571 cites W2106787323 @default.
• W1847568571 cites W2109888427 @default.
• W1847568571 cites W2112601576 @default.
• W1847568571 cites W2114300975 @default.
• W1847568571 cites W2114951959 @default.
• W1847568571 cites W2115393755 @default.
• W1847568571 cites W2120490293 @default.
• W1847568571 cites W2121215375 @default.
• W1847568571 cites W2125994015 @default.
• W1847568571 cites W2138922046 @default.
• W1847568571 cites W2148695112 @default.
• W1847568571 cites W2149598128 @default.
• W1847568571 cites W2150144117 @default.
• W1847568571 cites W2153942353 @default.
• W1847568571 cites W2211283429 @default.
• W1847568571 doi "https://doi.org/10.3978/j.issn.2218-6751.2013.11.01" @default.
• W1847568571 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4367606" @default.
• W1847568571 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25806278" @default.
• W1847568571 hasPublicationYear "2014" @default.
• W1847568571 type Work @default.
• W1847568571 sameAs 1847568571 @default.
• W1847568571 citedByCount "40" @default.
• W1847568571 countsByYear W18475685712015 @default.
• W1847568571 countsByYear W18475685712016 @default.
• W1847568571 countsByYear W18475685712017 @default.
• W1847568571 countsByYear W18475685712018 @default.
• W1847568571 countsByYear W18475685712019 @default.
• W1847568571 countsByYear W18475685712020 @default.
• W1847568571 countsByYear W18475685712021 @default.
• W1847568571 countsByYear W18475685712022 @default.
• W1847568571 countsByYear W18475685712023 @default.
• W1847568571 crossrefType "journal-article" @default.
• W1847568571 hasAuthorship W1847568571A5003582794 @default.
• W1847568571 hasAuthorship W1847568571A5013524621 @default.
• W1847568571 hasAuthorship W1847568571A5030744700 @default.
• W1847568571 hasAuthorship W1847568571A5089569598 @default.
• W1847568571 hasConcept C10882517 @default.
• W1847568571 hasConcept C121608353 @default.
• W1847568571 hasConcept C126322002 @default.
• W1847568571 hasConcept C143998085 @default.
• W1847568571 hasConcept C1491633281 @default.
• W1847568571 hasConcept C150903083 @default.
• W1847568571 hasConcept C203014093 @default.
• W1847568571 hasConcept C207001950 @default.
• W1847568571 hasConcept C26291073 @default.
• W1847568571 hasConcept C2776090121 @default.
• W1847568571 hasConcept C2776256026 @default.
• W1847568571 hasConcept C2777701055 @default.
• W1847568571 hasConcept C502942594 @default.
• W1847568571 hasConcept C54355233 @default.
• W1847568571 hasConcept C71924100 @default.
• W1847568571 hasConcept C86803240 @default.
• W1847568571 hasConcept C8891405 @default.
• W1847568571 hasConcept C90375314 @default.
• W1847568571 hasConceptScore W1847568571C10882517 @default.
• W1847568571 hasConceptScore W1847568571C121608353 @default.
• W1847568571 hasConceptScore W1847568571C126322002 @default.
• W1847568571 hasConceptScore W1847568571C143998085 @default.
• W1847568571 hasConceptScore W1847568571C1491633281 @default.
• W1847568571 hasConceptScore W1847568571C150903083 @default.
• W1847568571 hasConceptScore W1847568571C203014093 @default.
• W1847568571 hasConceptScore W1847568571C207001950 @default.
• W1847568571 hasConceptScore W1847568571C26291073 @default.
• W1847568571 hasConceptScore W1847568571C2776090121 @default.
• W1847568571 hasConceptScore W1847568571C2776256026 @default.
• W1847568571 hasConceptScore W1847568571C2777701055 @default.

• next